These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 3558361)
1. Characterization of the catalytic defect in the dysthrombin, Thrombin Quick. Henriksen RA; Owen WG J Biol Chem; 1987 Apr; 262(10):4664-9. PubMed ID: 3558361 [TBL] [Abstract][Full Text] [Related]
2. Substitution of valine for glycine-558 in the congenital dysthrombin thrombin Quick II alters primary substrate specificity. Henriksen RA; Mann KG Biochemistry; 1989 Mar; 28(5):2078-82. PubMed ID: 2719946 [TBL] [Abstract][Full Text] [Related]
3. Identification of the primary structural defect in the dysthrombin thrombin Quick I: substitution of cysteine for arginine-382. Henriksen RA; Mann KG Biochemistry; 1988 Dec; 27(26):9160-5. PubMed ID: 3242619 [TBL] [Abstract][Full Text] [Related]
4. The effect of bovine thrombomodulin on the specificity of bovine thrombin. Jakubowski HV; Kline MD; Owen WG J Biol Chem; 1986 Mar; 261(8):3876-82. PubMed ID: 3005304 [TBL] [Abstract][Full Text] [Related]
5. Identification of a congenital dysthrombin, thrombin Quick. Henriksen RA; Owen WG; Nesheim ME; Mann KG J Clin Invest; 1980 Nov; 66(5):934-40. PubMed ID: 6776145 [TBL] [Abstract][Full Text] [Related]
6. Evidence that activation of platelets and endothelium by thrombin involves distinct sites of interaction. Studies with the dysthrombin, Thrombin Quick I. Henriksen RA; Brotherton AF J Biol Chem; 1983 Nov; 258(22):13717-21. PubMed ID: 6358210 [TBL] [Abstract][Full Text] [Related]
7. Alpha-thrombin-catalyzed hydrolysis of fibrin I. Alternative binding modes and the accessibility of the active site in fibrin I-bound alpha-thrombin. Naski MC; Shafer JA J Biol Chem; 1990 Jan; 265(3):1401-7. PubMed ID: 2295636 [TBL] [Abstract][Full Text] [Related]
8. The role of thrombin's Tyr-Pro-Pro-Trp motif in the interaction with fibrinogen, thrombomodulin, protein C, antithrombin III, and the Kunitz inhibitors. Le Bonniec BF; Guinto ER; MacGillivray RT; Stone SR; Esmon CT J Biol Chem; 1993 Sep; 268(25):19055-61. PubMed ID: 8395526 [TBL] [Abstract][Full Text] [Related]
9. Role of the thrombin insertion loop 144-155. Study of thrombin mutations W148G, K154E and a thrombin-based synthetic peptide. Bouton MC; Plantier JL; Dembak M; Guillin MC; Rabiet MJ; Jandrot-Perrus M Eur J Biochem; 1995 Apr; 229(2):526-32. PubMed ID: 7744076 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of human thrombin assessed with different substrates and inhibitors. Characterization of fibrinopeptide binding interaction. Gorman JJ Biochim Biophys Acta; 1975 Dec; 412(2):273-82. PubMed ID: 1191680 [TBL] [Abstract][Full Text] [Related]
11. Formation of a ternary complex between thrombin, fibrin monomer, and heparin influences the action of thrombin on its substrates. Hogg PJ; Jackson CM J Biol Chem; 1990 Jan; 265(1):248-55. PubMed ID: 2294105 [TBL] [Abstract][Full Text] [Related]
12. Thrombin specificity with tripeptide chromogenic substrates: comparison of human and bovine thrombins with and without fibrinogen clotting activities. Sonder SA; Fenton JW Clin Chem; 1986 Jun; 32(6):934-7. PubMed ID: 3708816 [TBL] [Abstract][Full Text] [Related]
13. Difference in enzymatic properties between alpha-thrombin-staphylocoagulase complex and free alpha-thrombin. Kawabata S; Morita T; Iwanaga S; Igarashi H J Biochem; 1985 Apr; 97(4):1073-8. PubMed ID: 4030715 [TBL] [Abstract][Full Text] [Related]
14. Effects of protons on the thrombin-fibrinogen interaction. Picozzi M; Landolfi R; De Cristofaro R Eur J Biochem; 1994 Feb; 219(3):1013-21. PubMed ID: 8112314 [TBL] [Abstract][Full Text] [Related]
15. The thrombin high-affinity binding site on platelets is a negative regulator of thrombin-induced platelet activation. Structure-function studies using two mutant thrombins, Quick I and Quick II. Leong L; Henriksen RA; Kermode JC; Rittenhouse SE; Tracy PB Biochemistry; 1992 Mar; 31(9):2567-76. PubMed ID: 1547239 [TBL] [Abstract][Full Text] [Related]
16. The action of thrombin on peptide p-nitroanilide substrates: hydrolysis of Tos-Gly-Pro-Arg-pNA and D-Phe-Pip-Arg-pNA by human alpha and gamma and bovine alpha and beta-thrombins. Lottenberg R; Hall JA; Fenton JW; Jackson CM Thromb Res; 1982 Nov; 28(3):313-32. PubMed ID: 7179220 [TBL] [Abstract][Full Text] [Related]
17. Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin. Maraganore JM; Bourdon P; Jablonski J; Ramachandran KL; Fenton JW Biochemistry; 1990 Jul; 29(30):7095-101. PubMed ID: 2223763 [TBL] [Abstract][Full Text] [Related]
18. Active-site mapping of bovine and human blood coagulation serine proteases using synthetic peptide 4-nitroanilide and thio ester substrates. Cho K; Tanaka T; Cook RR; Kisiel W; Fujikawa K; Kurachi K; Powers JC Biochemistry; 1984 Feb; 23(4):644-50. PubMed ID: 6370301 [TBL] [Abstract][Full Text] [Related]
19. Thrombin Metz: characterization of the dysfunctional thrombin derived from a variant of human prothrombin. Rabiet MJ; Jandrot-Perrus M; Boissel JP; Elion J; Josso F Blood; 1984 Apr; 63(4):927-34. PubMed ID: 6546700 [TBL] [Abstract][Full Text] [Related]
20. Substitution of Gly-548 to Ala in the substrate binding pocket of prothrombin Perijá leads to the loss of thrombin proteolytic activity. Sekine O; Sugo T; Ebisawa K; Umeyama H; Iwahana H; Ruiz-Sáez A; de Bosch N; Matsudai M Thromb Haemost; 2002 Feb; 87(2):282-7. PubMed ID: 11858488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]